Perhaps.  Ido Bachelet and his research colleague, Ariel Munitz, have an interesting technique in mind reports EurekAlert.  The mast cells that produce the histamine and other pro-inflamation compounds have a receptor protein called CD300a.  Unfortunately, so do many other types of immune system cells so it can’t be used as a drug target.  They have instead created an antibody segment that targets both CD300a and a mast cell specific marker.

Tests in mice have confirmed that the antibody can eliminate four types of allergic diseases and severe, chronic asthma.

Ido is a doctoral candidate at the Hebrew University of Jerusalem School of Pharmacy and a first cousin of the president of Chile, Michelle Bachelet.